Status:
COMPLETED
Effect of Cold Atmospheric Plasma on Malassezia Folliculitis
Lead Sponsor:
The Second Hospital of Anhui Medical University
Collaborating Sponsors:
Hefei CAS Ion Medical and Technical Devices Co.,Ltd
Conditions:
Malassezia Folliculitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The cold atmospheric plasma may provide a new and effective method for the treatment of Malassezia folliculitis. The investigators conduct this randomized controlled trial to evaluate the effectivenes...
Detailed Description
Malassezia folliculitis is a common disease of young and middle-aged people. It is an inflammatory disease caused by Malassezia infection. Generally, Topical or systemic use of antifungal drugs are th...
Eligibility Criteria
Inclusion
- Patients are clinical presentation of Malassezia folliculitis in seborrheic areas.
- The diagnoses are mycologically verified by experienced laboratory technicians.
- Participants must be informed of the investigational nature of this study and be willing to provide written informed consent.
Exclusion
- Combined with other serious systemic diseases.
- History of topical corticosteroids within 2 weeks or history of systemic corticosteroids within 1 month.
- History of immunosuppressive drugs within 1 month.
- History of topical antifungal medication within 2 weeks or systemic antifungal medication within 3 months.
- Pregnant and lactating women.
Key Trial Info
Start Date :
August 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 17 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04886323
Start Date
August 3 2022
End Date
December 17 2023
Last Update
December 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Hospital of Anhui Medical University
Hefei, Anhui, China, 230000